These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25300950)

  • 1. Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?
    Stahl A; Hellstrom A; Smith LE
    Neonatology; 2014; 106(3):254-60. PubMed ID: 25300950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
    Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological treatment for retinopathy of prematurity].
    Stahl A; Agostini H; Jandeck C; Lagrèze W
    Ophthalmologe; 2011 Aug; 108(8):777-85; quiz 786-7. PubMed ID: 21853221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future trends in treatment of severe retinopathy of prematurity.
    Wallace DK; Wu KY
    Clin Perinatol; 2013 Jun; 40(2):297-310. PubMed ID: 23719311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
    Eldweik L; Mantagos IS
    Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Retinopathy of Prematurity--Use of Anti-VEGF Therapy.
    Tran KD; Cernichiaro-Espinosa LA; Berrocal AM
    Asia Pac J Ophthalmol (Phila); 2018; 7(1):56-62. PubMed ID: 29376233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivascular endothelial growth factor in the treatment of retinopathy of prematurity.
    Patel JR; Ranjan SS; Wasserman BN
    Curr Opin Ophthalmol; 2016 Sep; 27(5):387-92. PubMed ID: 27206263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.
    Hartnett ME
    Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity.
    Enríquez AB; Avery RL; Baumal CR
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):358-368. PubMed ID: 32694348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
    Stahl A; Sukgen EA; Wu WC; Lepore D; Nakanishi H; Mazela J; Moshfeghi DM; Vitti R; Athanikar A; Chu K; Iveli P; Zhao F; Schmelter T; Leal S; Köfüncü E; Azuma N;
    JAMA; 2022 Jul; 328(4):348-359. PubMed ID: 35881122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of anti-VEGF (anti-vascular endothelial growth factor) in Retinopathy of Prematurity (ROP)].
    González Viejo I; Ferrer Novella C; Pueyo Royo V
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):207-8. PubMed ID: 21798405
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity.
    VanderVeen DK; Cataltepe SU
    Semin Perinatol; 2019 Oct; 43(6):375-380. PubMed ID: 31174872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hot Topics in Retinopathy of Prematurity.
    Tsui I; Chu A
    Pediatr Ann; 2017 Nov; 46(11):e415-e422. PubMed ID: 29131921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in Retinopathy of Prematurity].
    Xu XX; Wu YJ; Wu HY; Hu YX; Cheng Y; Yan L; Rao J; Wu N; Wu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):261-266. PubMed ID: 31060684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Concepts in the Management of Retinopathy of Prematurity.
    Sternberg P; Durrani AK
    Am J Ophthalmol; 2018 Feb; 186():xxiii-xxxii. PubMed ID: 29109051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and novel therapies for retinopathy of prematurity - A review.
    Hellström A; Hård AL
    Early Hum Dev; 2019 Nov; 138():104846. PubMed ID: 31474316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-surgical treatment of stage 4A retinopathy of prematurity.
    Namvar E; Attar A
    BMC Ophthalmol; 2024 Apr; 24(1):180. PubMed ID: 38641774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.